BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35714473)

  • 1. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents.
    George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S
    Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
    Mishra P; Kumar A; Panda G
    Bioorg Med Chem; 2019 Mar; 27(6):895-930. PubMed ID: 30744931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
    Li Q; He S; Chen Y; Feng F; Qu W; Sun H
    Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease.
    Zhang X; He X; Chen Q; Lu J; Rapposelli S; Pi R
    Bioorg Med Chem; 2018 Feb; 26(3):543-550. PubMed ID: 29310862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
    de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
    Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Cheng X; Zhu G; Wei R; Ma Q; Yu L; Zhao Y; Tan Z; Liu W
    Eur J Med Chem; 2020 Feb; 187():111958. PubMed ID: 31865014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
    Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
    Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
    Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
    Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
    Nerella A; Jeripothula M
    Bioorg Med Chem Lett; 2021 Oct; 49():128212. PubMed ID: 34153471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel tacrine-indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease.
    Hamulakova S; Kudlickova Z; Janovec L; Mezencev R; Deckner ZJ; Chernoff YO; Janockova J; Ihnatova V; Bzonek P; Novakova N; Hepnarova V; Hrabinova M; Jun D; Korabecny J; Soukup O; Kuca K
    Future Med Chem; 2021 May; 13(9):785-804. PubMed ID: 33829876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
    Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
    Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer's disease.
    Macedo Vaz S; de Freitas Silva M; Dos Reis Rosa Franco G; Jorge R Guimarães M; Motta R da Silva F; Gonçalves Castro N; Alvim Guedes I; Dardenne LE; Amaral Alves M; Garrett da Costa R; Beserra Pinheiro G; Germino Veras L; Renata Mortari M; Pruccoli L; Tarozzi A; Viegas C
    Bioorg Med Chem; 2022 Oct; 71():116952. PubMed ID: 35930852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
    Kumar A; Tiwari A; Sharma A
    Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.
    Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H
    Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
    Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
    Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker.
    Liu Z; Zhang B; Xia S; Fang L; Gou S
    Eur J Med Chem; 2021 Feb; 212():112997. PubMed ID: 33189440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
    Kumar N; Kumar V; Anand P; Kumar V; Ranjan Dwivedi A; Kumar V
    Bioorg Med Chem; 2022 May; 61():116742. PubMed ID: 35398739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease.
    Kumar B; Thakur A; Dwivedi AR; Kumar R; Kumar V
    Curr Med Chem; 2022; 29(10):1757-1803. PubMed ID: 33982650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.